<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:06:52Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5798290" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5798290</identifier><datestamp>2018-02-07</datestamp><setSpec>jbc</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
      <journal-id journal-id-type="hwp">jbc</journal-id>
      <journal-id journal-id-type="pmc">jbc</journal-id>
      <journal-id journal-id-type="publisher-id">JBC</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Biological Chemistry</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0021-9258</issn>
      <issn pub-type="epub">1083-351X</issn>
      <publisher>
        <publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
        <publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5798290</article-id>
      <article-id pub-id-type="pmcid">PMC5798290</article-id>
      <article-id pub-id-type="pmc-uid">5798290</article-id>
      <article-id pub-id-type="pmid">29109152</article-id>
      <article-id pub-id-type="publisher-id">M117.809657</article-id>
      <article-id pub-id-type="doi">10.1074/jbc.M117.809657</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Protein Structure and Folding</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prodomainâgrowth factor swapping in the structure of pro-TGF-Î²1</article-title>
        <alt-title alt-title-type="short">Prodomainâgrowth factor swapping in pro-TGF-Î²1</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2163-6484</contrib-id>
          <name>
            <surname>Zhao</surname>
            <given-names>Bo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
          <xref ref-type="author-notes" rid="FN1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Shutong</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
          <xref ref-type="author-notes" rid="FN1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dong</surname>
            <given-names>Xianchi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Chafen</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Springer</surname>
            <given-names>Timothy A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="aff1">From the <label>â¡</label>Children's Hospital Boston and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115 and </aff>
        <aff id="aff2">the <label>Â§</label>Department of Medical Oncology and Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>2</label> To whom correspondence should be addressed:
<addr-line>Children's Hospital Boston and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 3 Blackfan Circle, Boston, MA 02115.</addr-line> E-mail: <email>springer_lab@crystal.harvard.edu</email>.</corresp>
        <fn fn-type="equal" id="FN1">
          <label>1</label>
          <p>Both authors contributed equally to this work.</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Edited by Norma Allewell</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>2</day>
        <month>2</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>293</volume>
      <issue>5</issue>
      <fpage>1579</fpage>
      <lpage>1589</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>7</month>
          <year>2017</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>10</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
        <copyright-year>2018</copyright-year>
        <copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
        <license license-type="open-access">
          <license-p><italic>Author's Choice</italic>âFinal version free via <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">Creative Commons CC-BY license</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="zbc00518001579.pdf"/>
      <abstract>
        <p>TGF-Î² is synthesized as a proprotein that dimerizes in the endoplasmic reticulum. After processing in the Golgi to cleave the N-terminal prodomain from the C-terminal growth factor (GF) domain in each monomer, pro-TGF-Î² is secreted and stored in latent complexes. It is unclear which prodomain and GF monomer are linked before proprotein convertase cleavage and how much conformational change occurs following cleavage. We have determined a structure of pro-TGF-Î²1 with the proprotein convertase cleavage site mutated to mimic the structure of the TGF-Î²1 proprotein. Structure, mutation, and model building demonstrate that the prodomain arm domain in one monomer is linked to the GF that interacts with the arm domain in the other monomer in the dimeric structure (<italic>i.e.</italic> the prodomain arm domain and GF domain in each monomer are swapped). Swapping has important implications for the mechanism of biosynthesis in the TGF-Î² family and is relevant to the mechanism for preferential formation of heterodimers over homodimers for some members of the TGF-Î² family. Our structure, together with two previous ones, also provides insights into which regions of the prodomainâGF complex are highly structurally conserved and which are perturbed by crystal lattice contacts.</p>
      </abstract>
      <kwd-group>
        <kwd>activin</kwd>
        <kwd>bone morphogenetic protein (BMP)</kwd>
        <kwd>crystal structure</kwd>
        <kwd>dimerization</kwd>
        <kwd>transforming growth factor beta (TGF-Î²)</kwd>
        <kwd>heterodimer</kwd>
        <kwd>prodomain</kwd>
        <kwd>proprotein convertase</kwd>
        <kwd>swapping</kwd>
        <kwd>Arg-Gly-Asp-Leu-any-any-Leu/Ile (RGDLXX(L/I))</kwd>
        <kwd>latent TGF-Î²-binding proteins (LTBPs)</kwd>
        <kwd>glycoprotein-A repetitions predominant protein (GARP)</kwd>
        <kwd>latency-associated peptide (LAP)</kwd>
        <kwd>growth factor (GF)</kwd>
        <kwd>Protein Data Bank (PDB)</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="award1">
          <funding-source>
            <institution-wrap>
              <institution>National Institutes of Health
</institution>
              <institution-id institution-id-type="open-funder-registry">10.13039/100000002</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>1R01AR67288</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body><sec sec-type="intro"><title>Introduction</title><p>The 33 members of the TGF-Î² family include bone morphogenetic proteins, growth and differentiation factors, activins, and inhibins. They regulate all aspects of embryogenesis, major organ development, and homeostasis (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). TGF-Î²1, -Î²2, and -Î²3 regulate development, cell fate, wound healing, and immune responses. TGF-Î² protein monomers are biosynthesized with an N-terminal prodomain of â¼250 residues and a C-terminal growth factor (GF)<xref ref-type="fn" rid="FN2"><sup>3</sup></xref> domain of â¼110 residues (<xref rid="B3" ref-type="bibr">3</xref><xref ref-type="bibr" rid="B4">â</xref><xref rid="B5" ref-type="bibr">5</xref>). In the endoplasmic reticulum, two monomers noncovalently associate, and both the prodomain and GF domain are covalently linked into disulfide-linked dimers. At the same time, the TGF-Î² prodomain also associates with and becomes disulfide-linked to âmilieu molecules,â such as latent TGF-Î²âbinding protein and glycoprotein-A repetitions predominant protein (GARP) (<xref rid="B6" ref-type="bibr">6</xref><xref ref-type="bibr" rid="B7">â</xref><xref rid="B9" ref-type="bibr">9</xref>). After transport to the Golgi, the polypeptide connection between the prodomain and GF is cleaved by a proprotein convertase. However, the GF remains strongly noncovalently bound to the prodomain, which keeps it latent during storage in extracellular milieus. ProdomainâGF interfaces are important not only for latency but also for biosynthesis. The prodomain is required for proper folding and dimerization of the GF domain (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). The C-terminal GF domain folds either concomitantly with or subsequently to the N-terminal prodomain (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>).</p><p>The structure of the pro-TGF-Î²1 dimer reveals that the prodomain dimer surrounds the GF dimer (<xref rid="B14" ref-type="bibr">14</xref>). Two arm domain monomers with a jelly roll, Î²-sandwich fold dimerize and are disulfide-linked at a bowtie knot and surround the GF on one side. On the other side, the N and C termini of the prodomain form a straitjacket that more loosely surrounds the GF. Each straitjacket monomer contains an Î±1-helix that intercalates between the two GF monomers, a latency lasso that wraps around the distal ends of each GF monomer, and an Î±2-helix that snuggles against the GFâarm domain interface. TGF-Î² cannot bind its receptors and signal until it is released from the prodomain (<italic>i.e.</italic> activated) (<xref rid="B15" ref-type="bibr">15</xref><xref ref-type="bibr" rid="B16">â</xref><xref rid="B17" ref-type="bibr">17</xref>). TGF-Î²1 and -Î²3 are activated by integrins that bind to an RGDL<italic>XX</italic>(I/L) motif in the prodomain (<xref rid="B18" ref-type="bibr">18</xref>). The motif locates to a long loop in the arm domain called the bowtie tail, because it follows the two bowtie cysteines that disulfide-link the two prodomain monomers. A structure of an Î±<sub>V</sub>Î²<sub>6</sub> integrin head bound to one monomer of a TGF-Î² dimer showed that integrin binding stabilizes an alternative conformation of the bowtie tail (<xref rid="B19" ref-type="bibr">19</xref>). Activation by integrin Î±<sub>V</sub>Î²<sub>6</sub> requires force application by the actin cytoskeleton, which is resisted by the milieu molecule, resulting in distortion of the prodomain and release of the GF (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B19" ref-type="bibr">19</xref>).</p><p>The dimeric pro-TGF-Î²1 crystal structure suggested that there might be a swap between the prodomain and GF domain (<xref rid="B14" ref-type="bibr">14</xref>). In the structure, the straitjacket and arm domain on one side of the dimer dyad axis interacted much more with the monomer on the same side than with that on the other side of the dyad axis. The structure that suggested swapping was of mature pro-TGF-Î²1, which was cleaved between each prodomain and GF monomer. The C terminus of one arm domain was closer to the N terminus of one GF monomer than the other, and if these were linked in the original monomer, this monomer would correspond to the arm domain and GF on opposite sides of the dyad axis, with the smallest amount of noncovalent association in the final structure (<xref rid="B14" ref-type="bibr">14</xref>). In other words, there would have been a swap.</p><p>Here, we have determined a structure of pro-TGF-Î²1 with the PC cleavage site mutated, to mimic the structure of the TGF-Î²1 proprotein before PC cleavage. The previous structure of the Î±<sub>V</sub>Î²<sub>6</sub> integrin head bound to one monomer of a TGF-Î² dimer also utilized PC cleavage siteâmutated pro-TGF-Î²1 (<xref rid="B19" ref-type="bibr">19</xref>); however, there was no description of the structure around the cleavage site. Furthermore, the complex was less well resolved (3.5 â«) than the current pro-TGF-Î²1 structure (2.9 â«) and had more residues missing in density adjacent to the PC cleavage site. Our structure and our analysis of the complex structure support arm domainâGF domain swapping. Swapping also has important implications because it can provide a mechanism for preferential formation of heterodimers over homodimers when a cell synthesizes monomers for two different TGF-Î² family members. Such heterodimers can display unique biological activities, as in the case of BMP-2/7 heterodimers (<xref rid="B20" ref-type="bibr">20</xref>), and can alter activity, as in the case of inhibin heterodimers compared with activin homodimers (<xref rid="B12" ref-type="bibr">12</xref>).</p><p>To gain a more comprehensive understanding of pro-TGF-Î²1 structure, we also describe differences among three pro-TGF-Î²1 crystal structures that appear unrelated to prodomain cleavage and relate to differences in crystal lattice contacts and flexibility of specific regions in pro-TGF-Î²1. Analysis of structural changes in the Î±<sub>V</sub>Î²<sub>6</sub> integrin complex with pro-TGF-Î²1 was limited to the region of contact between Î±<sub>V</sub>Î²<sub>6</sub> integrin and pro-TGF-Î²1 in the 5-page report (<xref rid="B19" ref-type="bibr">19</xref>). Here, we take advantage of two previous structures containing pro-TGF-Î²1 and the current one to provide the first comprehensive analysis of structural differences. These structural differences are relevant to TGF-Î² activation because rigidity is important for force transmission, and flexibility is important for release of the GF from the prodomain and for the ability of pro-TGF-Î²1 to covalently and noncovalently associate with structurally distinct milieu molecules (<xref rid="B6" ref-type="bibr">6</xref><xref ref-type="bibr" rid="B7">â</xref><xref rid="B9" ref-type="bibr">9</xref>).</p></sec><sec sec-type="results"><title>Results</title><sec><title>Crystal structure of pro-TGF-Î²1 before furin cleavage</title><p>We introduced an R249A mutation into the RHRR<sup>249</sup> PC cleavage site between the prodomain and GF domain of human pro-TGF-Î²1. SDS-PAGE showed that the R249A mutant is &gt;90% uncleaved, whereas WT protein is almost completely cleaved (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>A</italic>). Reducing SDS-PAGE of R249A mutant crystals showed a band corresponding to uncleaved pro-TGF-Î²1 monomer (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>), whereas porcine pro-TGF-Î²1 crystals show predominantly the cleaved prodomain (<xref rid="B14" ref-type="bibr">14</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p><bold>SDS-PAGE of purified pro-TGF-Î²1 and crystal</bold>. <italic>A</italic>, non-reducing (<italic>left</italic>) and reducing (<italic>right</italic>) SDS 4â20% PAGE of purified WT and R249A mutant pro-TGF-Î²1. <italic>B</italic>, reducing SDS-PAGE (10%) of a crystal of pro-TGF-Î²1 R249A mutant. Gels were stained with Coomassie Brilliant Blue.</p></caption><graphic xlink:href="zbc0011879120001"/></fig><p>We determined a crystal structure to a resolution of 2.9 â« of human R249A mutant pro-TGF-Î²1 (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F2">Fig. 2</xref><italic>A</italic>). The structure contains one monomer in the asymmetric unit; the other monomer of the dimer shown in the figures is a symmetry mate. We also reprocessed to higher resolution and re-refined the previously described, cleaved porcine pro-TGF-Î²1 structure (<xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="fig" rid="F2">Fig. 2</xref><italic>B</italic>). Despite the increase in resolution from 3.05 to 2.9 â«, the overall quality of the re-refined model and its <italic>R</italic><sub>free</sub> greatly improved (<xref ref-type="table" rid="T2">Table 2</xref>). The porcine, PC-cleaved structure has four crystallographically distinct monomers in the asymmetric unit but nonetheless has pseudosymmetry that resembles the symmetry of the human R249A mutant. Despite these overall similarities, the crystal lattice contacts show marked differences (<xref ref-type="fig" rid="F2">Fig. 2</xref>, <italic>C</italic> and <italic>D</italic>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p><bold>Statistics of X-ray diffraction and structure refinement of human pro-TGF-Î²1 R249A mutant (PDB entry <ext-link ext-link-type="pdb" xlink:href="5VQP">5VQP</ext-link>)</bold></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Pro-TGF-Î²1 R249A mutant (PDB entry <ext-link ext-link-type="pdb" xlink:href="5VQP">5VQP</ext-link>)</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1"><bold>Data collection statistics</bold></td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââSpace group</td><td align="left" rowspan="1" colspan="1">P 6 2 2</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââÎ±, Î², Î³ (degrees)</td><td align="left" rowspan="1" colspan="1">90, 90, 120</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââUnit cell (<italic>a</italic>, <italic>b</italic>, <italic>c</italic>), Ã</td><td align="left" rowspan="1" colspan="1">104.4, 104.4, 141.9</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââResolution range (Ã)</td><td align="left" rowspan="1" colspan="1">50.0â2.9 (3.0â2.9)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââCompleteness (%)</td><td align="left" rowspan="1" colspan="1">99.7 (99.9)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââNo. of unique reflections</td><td align="left" rowspan="1" colspan="1">10,672 (1,024)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââRedundancy</td><td align="left" rowspan="1" colspan="1">10.5 (10.9)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>merge</sub><xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref> (%)</td><td align="left" rowspan="1" colspan="1">17.1 (601)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>I</italic>/Ï</td><td align="left" rowspan="1" colspan="1">12.3 (0.5)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>CC</italic>Â½ (%)<xref ref-type="table-fn" rid="TF1-3"><italic><sup>c</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">99.9 (15.1)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââWavelength (Ã)</td><td align="left" rowspan="1" colspan="1">1.0332</td></tr><tr><td colspan="2" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Refinement statistics</bold></td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>work</sub><xref ref-type="table-fn" rid="TF1-4"><italic><sup>d</sup></italic></xref> (%)</td><td align="left" rowspan="1" colspan="1">25.2 (41.3)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>free</sub><xref ref-type="table-fn" rid="TF1-5"><italic><sup>e</sup></italic></xref> (%)</td><td align="left" rowspan="1" colspan="1">29.3 (42.3)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââBond RMSD (Ã)</td><td align="left" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââAngle RMSD (degrees)</td><td align="left" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââRamachandran plot<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref> (favored/allowed/outlier)</td><td align="left" rowspan="1" colspan="1">95.5/4.5/0</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââMolProbity percentile<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref> (Clashscore/geometry)</td><td align="left" rowspan="1" colspan="1">96/99</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââNo. of atoms</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââProtein</td><td align="left" rowspan="1" colspan="1">2576</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââCarbohydrates</td><td align="left" rowspan="1" colspan="1">39</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââNo. of <italic>cis</italic>-prolines</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>B</italic>-factors</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââProtein</td><td align="left" rowspan="1" colspan="1">127.0</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââCarbohydrates</td><td align="left" rowspan="1" colspan="1">221.8</td></tr></tbody></table><table-wrap-foot><fn fn-type="other" id="TF1-1"><p><italic><sup>a</sup></italic> Numbers in parentheses are for the highest-resolution shell.</p></fn><fn fn-type="other" id="TF1-2"><p><italic><sup>b</sup> R</italic><sub>merge</sub> = Î£<italic><sub>h</sub></italic> Î£<italic><sub>i</sub></italic>|<italic>Ii</italic>(<italic>h</italic>) â â©<italic>I</italic>(<italic>h</italic>)âª|/Î£<italic><sub>h</sub></italic>Î£<italic><sub>i</sub> Ii</italic>(<italic>h</italic>), where <italic>Ii</italic>(<italic>h</italic>) and â©<italic>I</italic>(<italic>h</italic>)âª are the <italic>i</italic>th and mean measurement of the intensity of reflection <italic>h</italic>.</p></fn><fn fn-type="other" id="TF1-3"><p><italic><sup>c</sup></italic> Pearson's correlation coefficient between average intensities of random half-data sets for unique reflections (<xref rid="B34" ref-type="bibr">34</xref>).</p></fn><fn fn-type="other" id="TF1-4"><p><italic><sup>d</sup> R</italic><sub>work</sub> = Î£<italic><sub>h</sub></italic>â<italic>F</italic><sub>obs</sub>(<italic>h</italic>)| â |<italic>F</italic><sub>calc</sub>(<italic>h</italic>)â/Î£<italic><sub>h</sub></italic>|<italic>F</italic><sub>obs</sub>(<italic>h</italic>)|, where <italic>F</italic><sub>obs</sub>(h) and <italic>F</italic><sub>calc</sub>(<italic>h</italic>) are the observed and calculated structure factors, respectively. No <italic>I</italic>/Ï(<italic>I</italic>) cutoff was applied.</p></fn><fn fn-type="other" id="TF1-5"><p><italic><sup>e</sup> R</italic><sub>free</sub> is the <italic>R</italic> value obtained for a test set of reflections consisting of a randomly selected â¼3% subset of the data set excluded from refinement.</p></fn><fn fn-type="other" id="TF1-6"><p><italic><sup>f</sup></italic> Calculated with MolProbity (<xref rid="B22" ref-type="bibr">22</xref>).</p></fn></table-wrap-foot></table-wrap><fig id="F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p><bold>Crystal structures, lattice contacts, and structural comparisons.</bold>
<italic>A</italic> and <italic>B</italic>, crystal structure of pro-TGF-Î²1 R249A mutant (<italic>A</italic>) and re-refined crystal structure of WT cleaved porcine pro-TGF-Î²1 (<italic>B</italic>). A <italic>ribbon cartoon</italic> is <italic>colored differently</italic> for straitjacket, arm, and GF domains. Disulfide bonds (<italic>yellow</italic>) are shown in <italic>stick representations</italic>. C termini of the prodomains and the N termini of the GFs are shown as <italic>spheres. CâE</italic>, lattice contacts in the crystal structures of uncleaved pro-TGF-Î²1 R249A PC mutant (<italic>C</italic>), cleaved pro-TGF-Î²1 WT (<italic>D</italic>), and uncleaved pro-TGF-Î²1 R249A PC mutant in complex with integrin Î±<sub>V</sub>Î²<sub>6</sub> (<italic>E</italic>). Crystal lattice contacts are shown as <italic>transparent surfaces</italic> with their <italic>outsides white</italic> and <italic>insides black. F</italic>, comparison of five representative pro-TGF-Î²1 prodomain monomers: the human R249A mutant 2.9 â« structure (PC mutant), WT porcine (cleaved chains C and D), and integrin-bound and unbound human R249A mutant monomers in a pro-TGF-Î²1 complex structure (<xref rid="B19" ref-type="bibr">19</xref>) (unbound chain H and bound chain G).</p></caption><graphic xlink:href="zbc0011879120002"/></fig><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p><bold>Statistics of X-ray diffraction and re-refinement of porcine pro-TGF-Î²1</bold></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Re-refined pro-TGF-Î²1 WT (PDB entry <ext-link ext-link-type="pdb" xlink:href="5VQF">5VQF</ext-link>)</th><th align="center" rowspan="1" colspan="1">Original pro-TGF-Î²1 WT (PDB entry <ext-link ext-link-type="pdb" xlink:href="3RJR">3RJR</ext-link>)</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1"><bold>Data collection statistics</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââSpace group</td><td align="left" rowspan="1" colspan="1">P 2<sub>1</sub></td><td align="left" rowspan="1" colspan="1">P 2<sub>1</sub></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââÎ±, Î², Î³ (degrees)</td><td align="left" rowspan="1" colspan="1">90, 96.7, 90</td><td align="left" rowspan="1" colspan="1">90, 96.7, 90</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââUnit cell (<italic>a</italic>, <italic>b</italic>, <italic>c</italic>), Ã</td><td align="left" rowspan="1" colspan="1">54.7, 126.9, 137.9</td><td align="left" rowspan="1" colspan="1">54.7, 127.1, 138.2</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââResolution range (Ã)</td><td align="left" rowspan="1" colspan="1">50.0â2.9 (3.0â2.9)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">50.0â3.05 (3.21â3.05)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââCompleteness (%)</td><td align="left" rowspan="1" colspan="1">96.1 (97.8)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">97.9 (96.5)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââNo. of unique reflections</td><td align="left" rowspan="1" colspan="1">39,918 (4,031)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">35,401 (4857)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââRedundancy</td><td align="left" rowspan="1" colspan="1">4.3 (4.3)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">5.6 (4.2)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>merge</sub><xref ref-type="table-fn" rid="TF2-2"><italic><sup>b</sup></italic></xref> (%)</td><td align="left" rowspan="1" colspan="1">5.2 (274)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">4.7 (75.2)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>I</italic>/Ï</td><td align="left" rowspan="1" colspan="1">15.3 (0.6)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">16.4 (1.8)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>CC</italic>Â½ (%)<xref ref-type="table-fn" rid="TF2-3"><italic><sup>c</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">99.9 (32.6)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">NA<xref ref-type="table-fn" rid="TF2-4"><italic><sup>d</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââWavelength (Ã)</td><td align="left" rowspan="1" colspan="1">1.0332</td><td align="left" rowspan="1" colspan="1">1.0332</td></tr><tr><td colspan="3" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Refinement statistics</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>work</sub><xref ref-type="table-fn" rid="TF2-5"><italic><sup>e</sup></italic></xref> (%)</td><td align="left" rowspan="1" colspan="1">23.9 (45.2)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">27.4 (36.7)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>free</sub><xref ref-type="table-fn" rid="TF2-6"><italic><sup>f</sup></italic></xref> (%)</td><td align="left" rowspan="1" colspan="1">28.0 (52.0)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td><td align="left" rowspan="1" colspan="1">31.1 (41.9)<xref ref-type="table-fn" rid="TF2-1"><italic><sup>a</sup></italic></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ââââBond RMSD (Ã)</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââAngle RMSD (degrees)</td><td align="left" rowspan="1" colspan="1">0.85</td><td align="left" rowspan="1" colspan="1">0.488</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââRamachandran plot<xref ref-type="table-fn" rid="TF2-7"><italic><sup>g</sup></italic></xref> (favored/allowed/outlier)</td><td align="left" rowspan="1" colspan="1">96.7/3.3/0</td><td align="left" rowspan="1" colspan="1">88.2/11/0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââMolProbity percentile<xref ref-type="table-fn" rid="TF2-7"><italic><sup>g</sup></italic></xref> (Clashscore/geometry)</td><td align="left" rowspan="1" colspan="1">98/100</td><td align="left" rowspan="1" colspan="1">97/98</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââNo. of atoms</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââProtein</td><td align="left" rowspan="1" colspan="1">10,658</td><td align="left" rowspan="1" colspan="1">10,843</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââCarbohydrates</td><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">112</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââNo. of <italic>cis</italic>-prolines</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââ<italic>B</italic>-factors</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââProtein</td><td align="left" rowspan="1" colspan="1">188.4</td><td align="left" rowspan="1" colspan="1">214.4</td></tr><tr><td align="left" rowspan="1" colspan="1">ââââââââCarbohydrates</td><td align="left" rowspan="1" colspan="1">266.4</td><td align="left" rowspan="1" colspan="1">257.4</td></tr></tbody></table><table-wrap-foot><fn fn-type="other" id="TF2-1"><p><italic><sup>a</sup></italic> Numbers in parentheses are for the highest resolution shell.</p></fn><fn fn-type="other" id="TF2-2"><p><italic><sup>b</sup> R</italic><sub>merge</sub> = Î£<italic><sub>h</sub></italic>Î£<italic><sub>i</sub></italic>|<italic>Ii</italic>(<italic>h</italic>) â â©<italic>I</italic>(<italic>h</italic>)âª|/Î£<italic><sub>h</sub></italic>Î£<italic><sub>i</sub>Ii</italic>(<italic>h</italic>), where <italic>Ii</italic>(<italic>h</italic>) and â©<italic>I</italic>(<italic>h</italic>)âª are the <italic>i</italic>th and mean measurement of the intensity of reflection <italic>h</italic>.</p></fn><fn fn-type="other" id="TF2-3"><p><italic><sup>c</sup></italic> Pearson's correlation coefficient between average intensities of random half-data sets for unique reflections (<xref rid="B34" ref-type="bibr">34</xref>).</p></fn><fn fn-type="other" id="TF2-4"><p><italic><sup>d</sup></italic> NA, not applicable.</p></fn><fn fn-type="other" id="TF2-5"><p><italic><sup>e</sup> R</italic><sub>work</sub> = Î£<italic><sub>h</sub></italic>â<italic>F</italic><sub>obs</sub>(<italic>h</italic>)| â |<italic>F</italic><sub>calc</sub>(<italic>h</italic>)â/Î£<italic><sub>h</sub></italic>|<italic>F</italic><sub>obs</sub>(h)|, where <italic>F</italic><sub>obs</sub>(<italic>h</italic>) and <italic>F</italic><sub>calc</sub>(<italic>h</italic>) are the observed and calculated structure factors, respectively. No <italic>I</italic>/Ï(<italic>I</italic>) cutoff was applied.</p></fn><fn fn-type="other" id="TF2-6"><p><italic><sup>f</sup> R</italic><sub>free</sub> is the <italic>R</italic> value obtained for a test set of reflections consisting of a randomly selected â¼3% subset of the data set excluded from refinement.</p></fn><fn fn-type="other" id="TF2-7"><p><italic><sup>g</sup></italic> Calculated with MolProbity (<xref rid="B22" ref-type="bibr">22</xref>).</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Structurally conserved and variant regions of pro-TGF-Î²1</title><p>We first describe the overall structure of furin-mutant pro-TGF-Î²1 and compare it with previous pro-TGF-Î²1 structures before focusing on structural alterations around the PC cleavage site. Comparisons give insights into regions of pro-TGF-Î²1 that are flexible and hence may be affected by lattice contacts in crystals, as opposed to regions of pro-TGF-Î²1 that are more structurally constrained. Studying these structural features is important in understanding pro-TGF-Î²1 biology, including reshaping of the straitjacket region by applied force to release the GF in TGF-Î²1 activation, force transmission from the integrin binding site through the arm domain to the straitjacket, and the ability of the N-terminal portion of the prodomain to noncovalently associate with and disulfide-link to structurally distinct milieu molecules (<xref rid="B6" ref-type="bibr">6</xref><xref ref-type="bibr" rid="B7">â</xref><xref rid="B9" ref-type="bibr">9</xref>). A single crystallographically unique furin-mutant pro-TGF-Î²1 is present in the current structure. Four unique monomers are present in re-refined, cleaved, porcine pro-TGF-Î²1; because chains A and C and B and D are similar to one another, we only show chains C and D in the figures. Four unique monomers are present in the Î±<sub>V</sub>Î²<sub>6</sub> complex with furin-mutant pro-TGF-Î² (<xref rid="B19" ref-type="bibr">19</xref>); because integrin-bound monomers D and H are similar and unbound monomers C and G are similar, we only show chains G and H in the figures. These five prodomain monomers are overlaid in <xref ref-type="fig" rid="F2">Fig. 2</xref><italic>F</italic>.</p><p>In the prodomain arm domain, Î²-strands Î²1 to Î²7 of the jelly roll Î²-sandwich fold are structurally invariant, as are major Î±-helices Î±2âÎ±4 of the arm domain, as shown in the overlay of the five representative prodomain monomers (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>F</italic>). Î²-Sheet domains are relatively resistant to force. The relatively rigid arm domain Î²-sandwich fold thus enables integrins bound to the RGDLATI motif to transmit force through the arm domain to the straitjacket elements that surround the TGF-Î²1 GF (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>Large structural alterations upon integrin binding in the remarkably long 30-residue bowtie tail that contains the integrin-binding RGDLATI motif have been described previously (<xref rid="B19" ref-type="bibr">19</xref>). In the human PC-mutant monomer described here, all residues in the bowtie tail can be traced, whereas 6â9 residues are disordered in previous structures. However, density is poor in some regions of the PC-mutant bowtie tail, consistent with large variation in this region between structures. The two-stranded bowtie Î²-ribbon in porcine PC-cleaved and human uncleaved pro-TGF-Î²1 (<xref ref-type="fig" rid="F2">Fig. 2</xref>, <italic>A</italic> and <italic>B</italic>) is a consequence of formation of a four-stranded super-Î²-sheet with a two-stranded bowtie Î²-ribbon from a neighboring molecule related by symmetry or pseudosymmetry. In the absence of such a lattice contact, no Î²-ribbon is present, and nine residues are disordered in the integrin-unbound monomer from the Î±<sub>V</sub>Î²<sub>6</sub> complex (<xref rid="B19" ref-type="bibr">19</xref>). Notably, the Î²1-Î²2 loop that neighbors the bowtie tail is also highly structurally variable (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>F</italic>). This loop corresponds to a long meander between arm domain Î²-strands 1 and 2. Backbone movement in the meander should facilitate reshaping of the neighboring bowtie tail.</p><p>In the straitjacket, the C-terminal portion of the prodomain Î±1-helix, which inserts between the two GF domain monomers, is highly conserved in position. The C-terminal end of the Î±1-helix interacts with residues 74â76 to form a fastener that surrounds one GF monomer; each portion of the fastener is also highly conserved in position (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>F</italic>). The Î±2-helix, which interacts with both the GF and the arm domain, is also highly conserved structurally among the five representative pro-TGF-Î²1 monomers. This conservation in position of the two fastener elements and the Î±2-helix correlates with the observation that they are the most force-resistant straitjacket elements when integrin and actin cytoskeletonâdependent pulling on pro-TGF-Î²1 is resisted by the Î±1-helix residues that link to milieu molecules (<italic>i.e.</italic> fastener and Î±2-helix disruption correlates with peaks in force during pulling) (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>In contrast, the latency lasso and N terminus of the prodomain are highly variable among representative straitjacket structures. In the human R249A mutant pro-TGF-Î²1 structure, the latency lasso is displaced up to 7 â« by a lattice contact relative to other structures (<italic>arrow</italic> in <xref ref-type="fig" rid="F2">Fig. 2</xref><italic>F</italic>), and two residues are disordered. Almost the entire latency lasso, residues 33â45, differs by 2 â« or more among the structures, showing that the lasso only loosely wraps around the GF. At the N terminus, residues 1â2 are disordered in the human R249A mutant. The following Î±1-helix is stabilized as Î±-helical by contacts with the Î±1-helix of a symmetry-related molecule in the crystal lattice, as also occurred in the previous porcine, PC-cleaved pro-TGF-Î²1 structure (<xref rid="B14" ref-type="bibr">14</xref>). In the absence of such lattice contacts in the integrin complex with pro-TGF-Î²1 (<xref rid="B19" ref-type="bibr">19</xref>), residues 1â9 are disordered or differ in conformation. Prodomain residues 1â9 have no contact with other portions of pro-TGF-Î²1 and correspond to an âassociation regionâ that contains Cys-4 that disulfide-links to latent TGF-Î²âbinding protein or GARP. Because these milieu molecules have no structural similarity, the association region must be able to adopt different conformations to noncovalently associate with them. Furthermore, one pro-TGF-Î²1 dimer associates with a single milieu molecule in asymmetric 2:1 complexes. Thus, the association regions of the two monomers bound to a milieu molecule must adopt different conformations to bind to distinct portions of a milieu molecule.</p></sec><sec><title>The structure around the PC cleavage site</title><p>The conformation of the growth factor domain N terminus in the R249A mutant pro-TGF-Î²1 monomer differs markedly from the two representative monomers in cleaved pro-TGF-Î²1 (<xref ref-type="fig" rid="F2">Figs. 2</xref> (<italic>A</italic> and <italic>B</italic>) and <xref ref-type="fig" rid="F3">3</xref> (<italic>AâC</italic>)). In the structures reported here, the terminal residues in the prodomain and GF bordering the PC cleavage region have main-chain density in simulated annealing composite omit maps contoured at 1 Ï (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M117.809657/DC1">Fig. S1</ext-link>). In the uncleaved R249A mutant 2.9 â« structure, we can trace the electron density for the polypeptide chain up to prodomain residue 242. After seven prodomain residues and the N-terminal GF residue missing in density, the trace of the GF begins with its second residue, residue 251. Residue 251 is present in the solvent-filled cavity between the arm domains and the GF in the center of the ring-shaped pro-TGF-Î²1 dimer (<xref ref-type="fig" rid="F2">Figs. 2</xref><italic>A</italic> and <xref ref-type="fig" rid="F3">3</xref> (<italic>AâD</italic>)). Residues 251â253 lack any stabilizing van der Waals or hydrogen bond interactions with neighboring residues. A neighboring molecule in the crystal lattice comes close to residue 253 (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>C</italic>) and decreases the space accessible to residues 251â253 but makes no specific contacts. The ordering of residues 251 and 252 in the absence of any interactions with visualized residues suggests that their position is stabilized by the linkage of residue 251 to disordered residues 243â250, which connect to ordered prodomain residue 242.</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p><bold>ProdomainâGF connections.</bold>
<italic>AâC</italic>, overlays of the PC cleavage region in different crystal structures: R249A PC mutant 2.9 â« structure chain A (PC mutant), WT porcine cleaved chains C and D (cleaved monomer C and cleaved monomer D), and integrin complex R249A PC mutant chains G and H (complex monomer G and complex monomer H). <italic>A</italic>, all five structures; <italic>B</italic> and <italic>C</italic>, individual comparisons of uncleaved and cleaved monomers. <italic>D</italic>, views of the two possible arm domainâGF connections in the TGF-Î²1 R249A PC mutant 2.9 â« structure, from terminal residues in one arm domain monomer (C-ter 1) to terminal residues in one GF monomer (N-ter 1) or the other monomer (N-ter 2). The gaps to be spanned are <italic>dashed. Spheres</italic> mark the carbon atom of C-ter 1 and nitrogen atoms of N-ter 1 and N-ter 2. Terminal residues are <italic>labeled</italic>. Prodomain and GF domains are shown in <italic>ribbon cartoon</italic> and <italic>surface representations</italic>, respectively. <italic>E</italic> and <italic>F</italic>, two possible arm domainâGF connections in integrin complex uncleaved pro-TGF-Î²1 R249A dimers. <italic>E</italic>, chains G+H; <italic>F</italic>, chains C+D. Views are identical to those in the <italic>bottom view</italic> in <italic>D</italic>, and other details are as in <italic>D</italic>.</p></caption><graphic xlink:href="zbc0011879120003"/></fig><p>In the mature, cleaved GF, the N terminus has a distinct conformation (<xref ref-type="fig" rid="F2">Figs. 2</xref><italic>B</italic> and <xref ref-type="fig" rid="F3">3</xref> (<italic>AâC</italic>)). Residues 252â258 in the mature GF are Î±-helical, in contrast to the much more extended conformation in the uncleaved GF. The conformations differ among the N termini of the crystallographically distinct GF monomers in cleaved WT pro-TGF-Î²1. Chains A and C show ordering beginning with N-terminal GF residue 250 (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>B</italic>). Chains B and D show ordering beginning with GF residue 253 (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>C</italic>). Nonetheless, the structural environments of the N-terminal residues of the cleaved GFs are similar overall in having close interactions with other GF residues, and none extend into the solvent-filled channel in the middle of the pro-TGF-Î²1 ring. The N terminus of the mature GF extends toward the Î±3-helix of the GF, which is highly variable in position in cleaved TGF-Î²1 pro-complexes and is disordered in the uncleaved GF of the R249A mutant pro-TGF-Î²1. In concert with movement of the Î±3-helix, the N terminus of the mature GF moves so that it remains in van der Waals contact with the GF Î±3-helix. As a consequence of the extension of residues 251â254 in uncleaved pro-TGF-Î²1 toward the solvent channel in the ring instead of toward the Î±3-helix, residue 251 adopts positions that differ by 8.8 â« in uncleaved compared with cleaved pro-TGF-Î²1 (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>B</italic>).</p><p>The overall structures of WT and R249A mutant pro-TGF-Î²1 show that there are no large-scale conformational changes in the prodomain or GF or their orientation with respect to one another that relate to separation of the prodomain from the GF by PC cleavage. The most significant difference localizes to the N terminus of the GF domain, which, as described above, is altered in orientation in the absence of cleavage. Eight residues (positions 243â250) linking the prodomain to the growth factor domain are missing in density, consistent with the need of flexibility to fit into the catalytic site of the PC protease.</p><p>We further examined the previously undescribed structure around the PC cleavage site in the two representative monomers (chains G and H) of pro-TGF-Î²1 complexes with integrin Î±<sub>V</sub>Î²<sub>6</sub> (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>A</italic>). Superposition of chains G and H from the complex on chain A from R249A mutant pro-TGF-Î²1 crystallized alone reveals further flexibility. In chains G and H, residues 241â258 and 241â249, respectively, are disordered, compared with residues 243â250 in chain A of pro-TGF-Î²1 alone (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>A</italic>). However, the positions of ordered residues 240 and 251â261 also differ markedly (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>A</italic>), correlating with the different lattice environments of the three R249A mutant monomers compared (<xref ref-type="fig" rid="F2">Fig. 2</xref>, <italic>C</italic> and <italic>E</italic>). Among the three monomers, differences of up to 2 â« in CÎ± position begin at prodomain residue Gln-240 and end at GF residue Glu-261. Thus, residues 240â261 (22 residues) are capable of remodeling to extend away from pro-TGF-Î²1 and fit into the PC cleavage site.</p></sec><sec><title>Evidence for arm domain and growth factor swapping</title><p>We used modeling and mutagenesis to establish which prodomainâGF connection in the 2.9 â« R249A mutant structure was physiologic. The most C-terminal residue with electron density in one prodomain (labeled <italic>C-ter 1</italic> in <xref ref-type="fig" rid="F3">Fig. 3</xref><italic>D</italic>) must link through disordered residues either to the N terminus of one GF monomer (N-ter 1; a distance of 18 â«) or to the N terminus of the other monomer (N-ter 2; a distance of 32 â«). Whereas a direct connection between C-ter 1 and N-ter 1 can be built over the 18-â« distance, the connection to N-ter 2 of 32 â« cannot be built straight, because fastener residues 72â74 and the GF dimer are in the way, and the polypeptide must curve around them as it goes through the central cavity of pro-TGF-Î² to connect. To test the feasibility of the alternative arm domainâGF connections, we built the residues missing in density using Modeler (<xref rid="B21" ref-type="bibr">21</xref>). As reported by MolProbity (<xref rid="B22" ref-type="bibr">22</xref>), the 32-â« distance could not be spanned without introducing substantial clashes, bad geometry, and bond length outliers (<italic>i.e.</italic> chain breaks). The 32-â« connection showed 100% bond length outliers over residues 242â251 for 20 of 20 models. As a further test, validation for deposition to the Protein Data Bank reported that the 32-â« connection was too long to be spanned for the number of missing residues. Moreover, lack of flexibility in the 32-â« connection would prohibit the remodeling required to fit into the PC protease active site cleft and would position the cleavage site in the center of the cavity of the pro-TGF-Î² ring, where it would be inaccessible to the large 90-kDa PC protease. In contrast, the 18-â« distance could easily be spanned by multiple conformations of the prodomainâGF linker, including those with the RHRR<sup>249</sup> PC recognition motif well exposed to solvent (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>A</italic>). Representatives of the 20 connections built by Modeler between C-ter 1 and N-ter 1 are shown in <italic>different colors</italic> in <xref ref-type="fig" rid="F4">Fig. 4</xref><italic>A</italic>, with the four residues in the PC recognition motif shown as <italic>small C</italic>Î±-<italic>atom spheres</italic>.</p><fig id="F4" orientation="portrait" position="float"><label>Figure 4.</label><caption><p><bold>Modeling and mutagenesis of the arm domainâGF linker region.</bold>
<italic>A</italic>, representative arm domainâGF connections (residues 243â250) built by MODELLER between the C-ter 1âN-ter 1 connection are shown as loops of different <italic>colors</italic> with CÎ± atoms of the RHRR PC cleavage site shown with <italic>small spheres</italic>. Residues 61 and 72, adjacent to the residues missing in density between the straitjacket and arm domain, are also marked with <italic>spheres</italic> (see âDiscussionâ). The remaining portions of pro-TGF-Î²1 are shown as <italic>surface representations. B</italic>, PC site mutations. <italic>C</italic>, WT and mutant pro-TGF-Î²1 co-expression with soluble GARP. Culture supernatants were incubated with StrepTactin-Sepharose (GE Healthcare) for 1 h. StrepTactin beads were washed and heated at 100 Â°C in reducing SDS sample buffer, and eluates were subjected to SDS-PAGE and stained with Coomassie Brilliant Blue. <italic>D</italic>, transient expression of WT and mutant pro-TGF-Î²1. Culture supernatants were subjected to reducing SDS-PAGE and Western blotting with antibody to the TGF-Î²1 prodomain (BAF246, R&amp;D Systems).</p></caption><graphic xlink:href="zbc0011879120004"/></fig><p>The positions of C-ter 1, N-ter 1, and N-ter 2 and their relation to the structural environment are shown for the pro-TGF-Î²1 integrin complex structure in <xref ref-type="fig" rid="F3">Fig. 3</xref>, <italic>E</italic> and <italic>F</italic>. Additionally, the terminal residues visualized in density and the distance that would be needed to connect the terminal residues (assuming a straight extended chain could be built) are compared in <xref ref-type="table" rid="T3">Table 3</xref>. The results show that the C-ter 1 and N-ter 1 linkages (between prodomain and GFs with the same chain IDs) are feasible, given the distances to be spanned and the number of missing residues (<xref ref-type="table" rid="T3">Table 3</xref>). In contrast, the distances to be spanned are always longer for C-ter 1 to N-ter 2 linkages (between prodomain and GFs with different chain IDs in <xref ref-type="table" rid="T3">Table 3</xref>). The number of missing residues is insufficient to span the required distance between C-ter 1 and N-ter 2; the straight line measurements in <xref ref-type="table" rid="T3">Table 3</xref> are underestimates, because the straight lines go through the GF domains, as shown in <xref ref-type="fig" rid="F3">Fig. 3</xref> (<italic>E</italic> and <italic>F</italic>). Overall, the model building for the R249A pro-TGF-Î²1 structure and structural analysis of the complex structure demonstrate that only one arm domainâGF connection, C-ter 1 to N-ter 1, is possible. Furthermore, comparisons among the structures in different crystal lattice environments demonstrate that flexibility around the cleavage site extends beyond residues that are disordered in the R249A pro-TGF-Î²1 structure and includes residues 240â261.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p><bold>Terminal residues bordering the PC cleavage site connectivity region and distances in the dimer structures</bold></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Structure</th><th align="center" rowspan="1" colspan="1">Prodomain C terminus</th><th align="center" rowspan="1" colspan="1">Growth factor N terminus</th><th align="center" rowspan="1" colspan="1">Terminal residues in each chain</th><th align="center" rowspan="1" colspan="1">Missing residues</th><th align="center" rowspan="1" colspan="1">Distance</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Ã</td></tr><tr><td align="left" rowspan="1" colspan="1">Pro-TGF-Î²1 R249A mutant (5VQP)</td><td align="left" rowspan="1" colspan="1">Chain A, Leu-242</td><td align="left" rowspan="1" colspan="1">Chain A, Leu-251</td><td align="left" rowspan="1" colspan="1">A, Leu-242; A, Leu-251</td><td align="left" rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">A, Leu-242; Sym<xref ref-type="table-fn" rid="TF3-1"><italic><sup>a</sup></italic></xref>/Leu-251</td><td align="left" rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">32</td></tr><tr><td align="left" rowspan="1" colspan="1">Pro-TGF-Î²1 dimer (G+H) in complex with integrin (5FFO)</td><td align="left" rowspan="1" colspan="1">Chain G, Gln-240</td><td align="left" rowspan="1" colspan="1">Chain G, Ala-250</td><td align="left" rowspan="1" colspan="1">G, Gln-240; G, Ala-250</td><td align="left" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G, Gln-240; H, Ser-259</td><td align="left" rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">46</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Chain H, Gln-240</td><td align="left" rowspan="1" colspan="1">Chain H, Ser-259</td><td align="left" rowspan="1" colspan="1">H, Gln-240; H, Ser-259</td><td align="left" rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">23</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">H, Gln-240; G, Ala-250</td><td align="left" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">39</td></tr><tr><td align="left" rowspan="1" colspan="1">Pro-TGF-Î²1 dimer (C+D) in complex with integrin (5FFO)</td><td align="left" rowspan="1" colspan="1">Chain C, Gln-240</td><td align="left" rowspan="1" colspan="1">Chain C, Ala-250</td><td align="left" rowspan="1" colspan="1">C, Gln-240; C, Ala-250</td><td align="left" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">21</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">C, Gln-240; D, Cys-256</td><td align="left" rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">47</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Chain D, Gln-240</td><td align="left" rowspan="1" colspan="1">Chain D, Cys-256</td><td align="left" rowspan="1" colspan="1">D, Gln-240; D, Cys-256</td><td align="left" rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">D, Gln-240; C, Ala-250</td><td align="left" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">39</td></tr></tbody></table><table-wrap-foot><fn fn-type="other" id="TF3-1"><p><italic><sup>a</sup></italic> Symmetry-related molecule.</p></fn></table-wrap-foot></table-wrap><p>To further characterize the prodomainâGF connection, we shortened it by deleting 2â6 residues. We hypothesized that the physiologic connection should be flexible to enable PC cleavage. Thus, we expected that the N-ter 1âC-ter 1 connection should be capable of being shortened, without disrupting proper folding of pro-TGF-Î²1. Because mammalian cells have endoplasmic reticulum quality control systems that require proper protein folding before secretion, we assayed for the effect of deletion mutations on pro-TGF-Î²1 secretion by 293T cell transfectants. We deleted 2, 4, or 6 residues, including the RHRR cleavage site, and introduced a glycine substitution to enable flexibility at the deletion position in the D2, D4, and D6 mutations (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>B</italic>). These mutations abolished PC cleavage and yet had no effect on the level of pro-TGF-Î²1 expression (<xref ref-type="fig" rid="F4">Fig. 4</xref>, <italic>C</italic> and <italic>D</italic>). The ability to substantially shorten the linker without affecting expression (<italic>i.e.</italic> folding) supports the shorter of the two connections.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>We describe here the crystal structure of a pro-TGF-Î²1 R249A mutant that is uncleaved by PC and contrast it with a re-refined structure of cleaved pro-TGF-Î²1. Clear differences are present adjacent to the cleavage site in at least three N-terminal GF residues. PC cleavage appears to result in no overall conformational changes in procomplex structure, although interesting differences are present distal from the cleavage site that appear to be influenced by lattice contacts that differ among structures. We also examine the previously undescribed structural features of an R249A mutant that was included in a complex structure with the head of integrin Î±<sub>V</sub>Î²<sub>6</sub> (<xref rid="B19" ref-type="bibr">19</xref>). The pro-TGF-Î²1 R249A mutant structure determined here is at higher resolution and has fewer residues missing in density in the PC cleavage region and thus provides a more definitive analysis of swapping; however, the complex structure confirms and extends the conclusions. The R249A mutant is a model for the structure of the pro-form of pro-TGF-Î²1 present during biosynthesis, after folding is completed in the endoplasmic reticulum, and before cleavage by a PC protease in the Golgi. As such, it provides the closest glimpse yet available for the connectivities between prodomains and GF domains within individual pro-TGF-Î²1 monomers during biosynthesis.</p><p>SDS-PAGE of purified pro-TGF-Î²1 R249A mutant protein and crystals formed from it, along with the distinct conformation of the GF N terminus, show that the prodomainâGF linker region was intact in this structure, although the electron density was too weak to be traced. Distance measurements and modeling based on this structure unambiguously define the shortest of two possible prodomainâGF connections as that which is physiologic. These results were further supported by the demonstration that shortening of the prodomainâGF linker by deletion of 2â6 residues had no adverse impact on the amount of pro-TGF-Î²1 biosynthesis or secretion. We therefore concluded that the prodomain arm domain is connected to the GF with which it has no noncovalent interaction. Arm domains and GF domains that are derived from the same precursor monomers are shown in the <italic>same color</italic> in <xref ref-type="fig" rid="F5">Fig. 5</xref><italic>A</italic>. The arm domain noncovalently interacts with the GF domain derived from the other precursor monomer and forms a super-Î²-sheet with it; the total binding interface is 375 â«<sup>2</sup>.</p><fig id="F5" orientation="portrait" position="float"><label>Figure 5.</label><caption><p><bold>ProdomainâGF swapping.</bold>
<italic>AâC</italic>, straitjacket, arm domain, and GF connectivity in pro-TGF-Î²1 (<italic>A</italic>), pro-activin A (<italic>B</italic>), and pro-BMP9 (<italic>C</italic>). Straitjacket, arm, and GF elements are shown in the <italic>same color</italic> if they belong to the same precursor monomer; elements are numbered <italic>1</italic> or <italic>2</italic> according to their monomers. They are labeled <italic>1</italic> or <italic>2</italic> when the monomer from which they are derived is unknown and are given a <italic>distinctive color</italic> (straitjackets in pro-TGF-Î²1 and GFs in pro-BMP9).</p></caption><graphic xlink:href="zbc0011879120005"/></fig><p>Our results also explain why arm-GF swapping is found and intramonomer association does not occur. The arm and GF within a precursor monomer could not associate with one another to form a super-Î²-sheet as described in the previous paragraph for the arm and GF domains from different monomers, because, as we have shown, the distance, which corresponds to the N1-C2 connection in the dimer, is too long to be spanned. Many other factors that favor swapping may also come into play, including maximizing the entropy of the polar residues around the cleavage site by not straightening them and not confining them to the narrow channel in the middle of the pro-TGF-Î²1 ring. The channel is more crowded than it appears in our figures, because it also includes disordered residues that connect Gly-61 in the straitjacket to Ala-72 in the arm domain (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>A</italic>). Arm domainâGF domain swapping must occur in the endoplasmic reticulum concomitant with protein folding and formation of intra- and intermonomer disulfide bonds and before PC cleavage in the Golgi.</p><p>As there was little discussion in a paper on an integrin complex on structural variation in pro-TGF-Î²1 aside from that associated with integrin binding (<xref rid="B19" ref-type="bibr">19</xref>), we have described this variation here and extended it to the newly determined pro-complex structure. The latency lasso and association region are remarkably malleable. In contrast, other portions of the straitjacket, including the C-terminal portion of the Î±1-helix, its interaction with the fastener, and the Î±2-helix, are structurally conserved. The arm domain jelly roll fold is also structurally conserved. These observations correlate with the dynamics of these regions measured by hydrogenâdeuterium exchange (<xref rid="B19" ref-type="bibr">19</xref>). We have further observed that residues 240â261 flanking the PC cleavage site at Arg-249 are either disordered or variable in structure in different lattice environments. The sequence in this region, <sup>240</sup>QSSRHR(R/A)<sup>249</sup>ALDTNYCSSTE<sup>261</sup> is largely polar and includes a Cys residue in a partially disordered disulfide bond.</p><p>It is interesting to examine our conclusions on prodomainâGF connectivity in pro-TGF-Î²1 in light of recent structures of pro-complexes for BMP-9 (<xref rid="B23" ref-type="bibr">23</xref>) and activin (<xref rid="B24" ref-type="bibr">24</xref>). In pro-TGF-Î²1, we have shown that the arm domain and the GF domain more distal in the dimeric structure are derived from the same monomer. The arm and GF domains derived from one monomer are <italic>colored green</italic>, and those from the other monomer are in <italic>gold</italic> in <xref ref-type="fig" rid="F5">Fig. 5</xref><italic>A</italic>. Whereas the connection between the arm domain and the GF in precursor monomers has been assigned here, the connection between the straitjacket and the arm domain is undefined. In pro-TGF-Î²1, the straitjacket shows density from the Î±1-helix through the latency lasso through to the end of the Î±2-helix. There is then a gap, with density missing between residues 61 and 72 that connect the straitjacket to the arm domain. The disordered residues lie in the central solvent-filled cavity in the pro-TGF-Î²1 ring (<xref ref-type="fig" rid="F2">Figs. 2</xref><italic>A</italic>, <xref ref-type="fig" rid="F4">4</xref><italic>A</italic>, and <xref ref-type="fig" rid="F5">5</xref><italic>A</italic>). Whether the straitjacket connects to the arm domain on the other side of the dimer or on the same side is not known. In the uncleaved R249A structure, the <italic>light blue-colored</italic> straitjacket would connect to the <italic>green</italic> arm domain over a distance of 12.2 â«, and the <italic>orange</italic> straitjacket on the other side of the dimer would connect to the <italic>green</italic> arm domain over a distance of 20.2 â« (<italic>C</italic>Î± <italic>spheres</italic> and <italic>dashed lines</italic> in <xref ref-type="fig" rid="F5">Fig. 5</xref><italic>A</italic>). Either distance can be spanned by the 10 missing residues. Therefore, it is not possible to know whether the straitjacket and arm domain that are close or distal to one another are in the same polypeptide chain, and chain IDs for the straitjacket region in current pro-TGF-Î²1 structures are arbitrary.</p><p>For pro-activin A, structures were determined with and without cleavage at a 3C protease site that replaced the PC site (<xref rid="B24" ref-type="bibr">24</xref>). The prodomainâGF linker was disordered in both structures; however, based on the distance to be spanned, it was concluded that the arm domainâGF connection was the same as described here for pro-TGF-Î²1 (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>B</italic>). In other words, in both pro-TGF-Î²1 and pro-activin A, the arm domain connects to the GF with which it has no noncovalent interaction and intimately noncovalently interacts with the GF in the other monomer. Interestingly, in pro-activin A, a highly ordered helix (Î±3) connects the straitjacket on one side of the dimer dyad axis to the arm domain on the opposite side (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>B</italic>). Thus, in <xref ref-type="fig" rid="F5">Fig. 5</xref><italic>B</italic>, each pro-activin A precursor monomer has a <italic>single color</italic> to show monomer connectivity. It can be seen that there are two types of swaps. In each monomer, the straitjacket connects to the arm domain on the opposite side of the dimer dyad axis; furthermore, each arm domain connects to the GF on the opposite side of the dyad axis. This type of swapping is also possible in pro-TGF-Î²1.</p><p>Pro-BMP-9 (<xref rid="B23" ref-type="bibr">23</xref>) is yet another case. It lacks density for the Î±1-helix and latency lasso yet shows good density for the Î±2-helix. Furthermore, the density between the Î±2-helix and the arm domain is continuous and connects the Î±2-helix to the same arm domain with which it noncovalently associates (shown in the <italic>same color</italic> in <xref ref-type="fig" rid="F5">Fig. 5</xref><italic>C</italic>). Thus, pro-BMP-9 lacks the swap between the straitjacket and the arm domain seen in pro-activin A. However, the Î±1-helix and latency lasso are missing in density in pro-BMP9, and therefore it is important to consider whether a putative straitjacketâarm domain swap present in the pro-form could have been reversed by conformational change after PC cleavage. The putative swap is in the loop between the straitjacket Î±2-helix and arm domain Î²1-strand. This loop is 12 residues longer in pro-TGF-Î²1 and 17 residues longer in pro-activin A than in pro-BMP-9 (<xref rid="B2" ref-type="bibr">2</xref>). Even building a model of pro-BMP-9 with a conformation in which the two arm domains associate closely, as in pro-TGF-Î²1 (<xref rid="B23" ref-type="bibr">23</xref>), it appears that the loop between the Î±2-helix and Î²1-strand is not long enough for such swapping to occur in pro-BMP-9. Thus, in pro-BMP-9, swapping between the straitjacket and arm domains is neither observed experimentally nor feasible in an alternative pro-complex conformation. It thus appears that the TGF-Î² family members activin A and BMP-9 differ in their straitjacketâarm domain swaps.</p><p>Swapping between the straitjacket, arm domain, and GF domain has profound biological implications for the TGF-Î² family at large. TGF-Î² family members form homodimers as well as heterodimers. Inhibin-Î² subunits homodimerize to form activins, such as pro-activin A, as discussed above, and heterodimerize with inhibin-Î± subunits to form inhibins (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>). Some BMP heterodimers show higher activity than homodimers <italic>in vitro</italic> and <italic>in vivo</italic>, including BMP-4/7 (<xref rid="B27" ref-type="bibr">27</xref><xref ref-type="bibr" rid="B28">â</xref><xref rid="B29" ref-type="bibr">29</xref>) and BMP-2/7 (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B30" ref-type="bibr">30</xref><xref ref-type="bibr" rid="B31">â</xref><xref rid="B32" ref-type="bibr">32</xref>). Although structures of biologically relevant heterodimers are not available, the structure here of uncleaved pro-TGF-Î²1 together with structures of pro-activin A and pro-BMP-9 suggest that swapping of two elements of the prodomain with the GF domain could provide mechanisms for preferential formation of heterodimers over homodimers for some TGF-Î² family members. More specifically, we show that the arm domain of one monomer interacts with the GF domain of the other monomer. Thus, the arm domain of TGF-Î² family member 1 may have higher affinity for the GF in a second monomer of TGF-Î² family member 2 than a second monomer of identical family member 1. Similarly, the arm domain of family member 2 may have higher affinity for the GF in a second monomer of TGF-Î² family member 1 than in a second monomer of identical family member 2. In this scenario, when a cell co-expresses family members 1 and 2, during biosynthesis in the endoplasmic reticulum, formation of heterodimers between family members 1 and 2 will be favored over formation of homodimers of family member 1 or 2.</p><p>The TGF-Î² family is very diverse, with 33 genes giving rise to a larger number of homo- and heterodimers that regulate all aspects of development and homeostasis. The TGF-Î² superfamily is larger than other extracellular protein families that regulate development, including the Wnt, Frizzled, Delta/Jagged, and Notch families (<xref rid="B2" ref-type="bibr">2</xref>). Multiple families that contain similar cystine-knot fold GF domains also emerged at the dawn of metazoans, but the TGF-Î² family multiplied more than any other. TGF-Î² has a larger prodomain than any other cystine-knot fold cytokine, and it has been argued that this size, combined with the capacity for diversification of the prodomain, contributed to the evolutionary success of the TGF-Î² family (<xref rid="B2" ref-type="bibr">2</xref>). It has become increasingly clear that prodomains are of key importance in the physiology of the TGF-Î² family. The study here and comparisons with other pro-complexes extend our understanding of how TGF-Î² family prodomains interact with and regulate their GFs.</p></sec><sec sec-type="methods"><title>Experimental procedures</title><sec><title>Protein expression and purification</title><p>The human pro-TGF-Î²1 expression construct contains an N-terminal His<sub>8</sub> tag, followed by a streptavidin-binding protein tag and a 3C protease site (<xref rid="B14" ref-type="bibr">14</xref>). A C4S mutation and <italic>N</italic>-glycosylation site mutations N107Q and N147Q were introduced to facilitate protein expression, secretion, and crystallization. In addition, R249A, D2G, D4G, and D6G PC site mutations (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>B</italic>) were introduced. R249A mutant protein expression and purification were as described (<xref rid="B19" ref-type="bibr">19</xref>). Human pro-TGF-Î²1 constructs with no N-terminal tags, WT Cys-4 and R249A, D2G, D4G, and D6G PC site mutations (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>B</italic>), were also used for co-expression with GARP.</p></sec><sec><title>Cell culture and transfection</title><p>HEK293S GnTI<sup>â</sup> stable cell lines expressing soluble GARP protein with N-terminal His<sub>8</sub> tag, streptavidin-binding protein tag, and a 3C protease site and HEK293T cells were maintained in DMEM supplemented with 10% FBS, 4 m<sc>m</sc>
<sc>l</sc>-glutamine, and 1% non-essential amino acids. Cells were transiently transfected with WT and mutant pro-TGF-Î²1 constructs using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Culture supernatants were harvested after 48 h to test for pro-TGF-Î²1 expression and co-expression with GARP.</p></sec><sec><title>Crystal structures</title><p>Crystals of pro-TGF-Î²1 R249A mutant (1 Î¼l, 10 mg/ml, 20 m<sc>m</sc> Tris-HCl, pH 8.0, 150 m<sc>m</sc> NaCl) were formed in hanging drops at 16 Â°C with 1 Î¼l of 10% dioxane, 100 m<sc>m</sc> MES, pH 6.5, 1.7 <sc>m</sc> (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> (well solution). Crystals were cryoprotected with well solution containing 31.4% Li<sub>2</sub>SO<sub>4</sub>. Diffraction data from GM/CA-CAT beamline 23-ID of the Advanced Photon Source at the Argonne National Laboratory were processed with XDS (<xref rid="B33" ref-type="bibr">33</xref>) with cross-correlation to determine the diffraction limit (<xref rid="B34" ref-type="bibr">34</xref>). Structures were solved with molecular replacement by PHASER (<xref rid="B35" ref-type="bibr">35</xref>) with cleaved pro-TGF-Î²1 (Protein Data Bank entry <ext-link ext-link-type="pdb" xlink:href="3RJR">3RJR</ext-link>) as the search model. The previous cleaved pro-TGF-Î²1 data set (<xref rid="B14" ref-type="bibr">14</xref>) was reprocessed using XDS (<xref rid="B33" ref-type="bibr">33</xref>) with cross-correlation to determine the diffraction limit (<xref rid="B34" ref-type="bibr">34</xref>) to a resolution of 2.9 â«. Structures were refined with PHENIX (<xref rid="B36" ref-type="bibr">36</xref>), manually built with Coot, and validated with MolProbity (<xref rid="B22" ref-type="bibr">22</xref>).</p></sec><sec><title>Modeling</title><p>We used the MODELLER version 9.12 loop modeling protocol (<xref rid="B21" ref-type="bibr">21</xref>) to build and refine the eight missing residues between the prodomain and GF. Crystallographically defined regions were kept fixed. Ten loop models were built for each of the two connections, assessed based on the DOPE score (<xref rid="B37" ref-type="bibr">37</xref>), and validated using MolProbity (<xref rid="B22" ref-type="bibr">22</xref>).</p></sec></sec><sec><title>Author contributions</title><p>T. A. S. and B. Z. designed the experiments and wrote the manuscript. B. Z. carried out the biochemical studies and crystallization. X. D. performed data collection. B. Z., S. X., and X. D. performed structure determination. C. L. participated in the experiment design and data analysis.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplemental Data</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_293_5_1579__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="10.1074_M117.809657_jbc.M117.809657-1.pdf"/>
</supplementary-material>
</sec>
</body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>This work was supported by National Institutes of Health Grant R01 AR067288. <named-content content-type="COI-statement">The authors declare that they have no conflicts of interest with the contents of this article</named-content>. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
      </fn>
      <fn fn-type="other">
        <p>The atomic coordinates and structure factors (codes <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=5VQF">5VQF</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=5VQP">5VQP</ext-link>) have been deposited in the Protein Data Bank (<ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/">http://wwpdb.org/</ext-link>).</p>
      </fn>
      <fn fn-type="supplementary-material">
        <p>This article contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M117.809657/DC1">Fig. S1</ext-link>.</p>
      </fn>
    </fn-group>
    <fn-group content-type="abbreviations">
      <fn id="FN2">
        <label>3</label>
        <p>The abbreviations used are:
<def-list><def-item><term id="G1">GF</term><def><p>growth factor</p></def></def-item><def-item><term id="G2">GARP</term><def><p>glycoprotein-A repetitions predominant protein</p></def></def-item><def-item><term id="G3">PDB</term><def><p>Protein Data Bank</p></def></def-item><def-item><term id="G4">RMSD</term><def><p>root mean square deviation</p></def></def-item><def-item><term id="G5">PC</term><def><p>proprotein convertase.</p></def></def-item></def-list></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgment</title>
      <p>For crystallography, we thank GM/CA-CAT beamline 23-ID at the Advanced Photon Source.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Robertson</surname><given-names>I. B.</given-names></name>, and <name name-style="western"><surname>Rifkin</surname><given-names>D. B.</given-names></name></person-group> (<year>2013</year>) <article-title>Unchaining the beast; insights from structural and evolutionary studies on TGFÎ² secretion, sequestration, and activation</article-title>. <source>Cytokine Growth Factor Rev</source>. <volume>24</volume>, <fpage>355</fpage>â<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1016/j.cytogfr.2013.06.003</pub-id>
<?supplied-pmid 23849989?><pub-id pub-id-type="pmid">23849989</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hinck</surname><given-names>A. P.</given-names></name>, <name name-style="western"><surname>Mueller</surname><given-names>T. D.</given-names></name>, and <name name-style="western"><surname>Springer</surname><given-names>T. A.</given-names></name></person-group> (<year>2016</year>) <article-title>Structural Biology and Evolution of the TGF-Î² family</article-title>. <source>Cold Spring Harb. Perspect. Biol</source>. <volume>8</volume>, <fpage>a022103</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a022103</pub-id>
<?supplied-pmid 27638177?><pub-id pub-id-type="pmid">27638177</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gentry</surname><given-names>L. E.</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>N. R.</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Brunner</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Ranchalis</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Twardzik</surname><given-names>D. R.</given-names></name>, <name name-style="western"><surname>Lioubin</surname><given-names>M. N.</given-names></name>, <name name-style="western"><surname>Marquardt</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Purchio</surname><given-names>A. F.</given-names></name></person-group> (<year>1987</year>) <article-title>Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells</article-title>. <source>Mol. Cell Biol</source>. <volume>7</volume>, <fpage>3418</fpage>â<lpage>3427</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.7.10.3418</pub-id>
<?supplied-pmid 3479680?><pub-id pub-id-type="pmid">3479680</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wakefield</surname><given-names>L. M.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Flanders</surname><given-names>K. C.</given-names></name>, and <name name-style="western"><surname>Sporn</surname><given-names>M. B.</given-names></name></person-group> (<year>1988</year>) <article-title>Latent transforming growth factor-Î² from human platelets: a high molecular weight complex containing precursor sequences</article-title>. <source>J. Biol. Chem</source>. <volume>263</volume>, <fpage>7646</fpage>â<lpage>7654</lpage>
<?supplied-pmid 3163692?><pub-id pub-id-type="pmid">3163692</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Khalil</surname><given-names>N.</given-names></name></person-group> (<year>1999</year>) <article-title>TGF-Î²: from latent to active</article-title>. <source>Microbes Infect</source>. <volume>1</volume>, <fpage>1255</fpage>â<lpage>1263</lpage>
<pub-id pub-id-type="doi">10.1016/S1286-4579(99)00259-2</pub-id>
<?supplied-pmid 10611753?><pub-id pub-id-type="pmid">10611753</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Miyazono</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Olofsson</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Colosetti</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Heldin</surname><given-names>C. H.</given-names></name></person-group> (<year>1991</year>) <article-title>A role of the latent TGF-Î²1-binding protein in the assembly and secretion of TGF-Î²1</article-title>. <source>EMBO J</source>. <volume>10</volume>, <fpage>1091</fpage>â<lpage>1101</lpage>
<?supplied-pmid 2022183?><pub-id pub-id-type="pmid">2022183</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stockis</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Colau</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Coulie</surname><given-names>P. G.</given-names></name>, and <name name-style="western"><surname>Lucas</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>) <article-title>Membrane protein GARP is a receptor for latent TGF-Î² on the surface of activated human Treg</article-title>. <source>Eur. J. Immunol</source>. <volume>39</volume>, <fpage>3315</fpage>â<lpage>3322</lpage>
<pub-id pub-id-type="doi">10.1002/eji.200939684</pub-id>
<?supplied-pmid 19750484?><pub-id pub-id-type="pmid">19750484</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>D. Q.</given-names></name>, <name name-style="western"><surname>Andersson</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ramsey</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Unutmaz</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Shevach</surname><given-names>E. M.</given-names></name></person-group> (<year>2009</year>) <article-title>GARP (LRRC32) is essential for the surface expression of latent TGF-Î² on platelets and activated FOXP3+ regulatory T cells</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>106</volume>, <fpage>13445</fpage>â<lpage>13450</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0901944106</pub-id>
<?supplied-pmid 19651619?><pub-id pub-id-type="pmid">19651619</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Springer</surname><given-names>T. A.</given-names></name></person-group> (<year>2012</year>) <article-title>GARP regulates the bioavailability and activation of TGF-Î²</article-title>. <source>Mol. Biol. Cell</source>
<volume>23</volume>, <fpage>1129</fpage>â<lpage>1139</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.E11-12-1018</pub-id>
<?supplied-pmid 22278742?><pub-id pub-id-type="pmid">22278742</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>A. M.</given-names></name>, and <name name-style="western"><surname>Mason</surname><given-names>A. J.</given-names></name></person-group> (<year>1990</year>) <article-title>Requirement for activin A and transforming growth factor-Î²1 pro-regions in homodimer assembly</article-title>. <source>Science</source>
<volume>247</volume>, <fpage>1328</fpage>â<lpage>1330</lpage>
<pub-id pub-id-type="doi">10.1126/science.2315700</pub-id>
<?supplied-pmid 2315700?><pub-id pub-id-type="pmid">2315700</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gentry</surname><given-names>L. E.</given-names></name>, and <name name-style="western"><surname>Nash</surname><given-names>B. W.</given-names></name></person-group> (<year>1990</year>) <article-title>The pro domain of pre-pro-transforming growth factor Î²1 when independently expressed is a functional binding protein for the mature growth factor</article-title>. <source>Biochemistry</source>
<volume>29</volume>, <fpage>6851</fpage>â<lpage>6857</lpage>
<pub-id pub-id-type="doi">10.1021/bi00481a014</pub-id>
<?supplied-pmid 2397217?><pub-id pub-id-type="pmid">2397217</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Walton</surname><given-names>K. L.</given-names></name>, <name name-style="western"><surname>Makanji</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wilce</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>K. L.</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>D. M.</given-names></name>, and <name name-style="western"><surname>Harrison</surname><given-names>C. A.</given-names></name></person-group> (<year>2009</year>) <article-title>A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor Î² (TGFÎ²) ligands</article-title>. <source>J. Biol. Chem</source>. <volume>284</volume>, <fpage>9311</fpage>â<lpage>9320</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M808763200</pub-id>
<?supplied-pmid 19193648?><pub-id pub-id-type="pmid">19193648</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Belville</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Van Vlijmen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ehrenfels</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pepinsky</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rezaie</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Picard</surname><given-names>J. Y.</given-names></name>, <name name-style="western"><surname>Josso</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>di Clemente</surname><given-names>N.</given-names></name>, and <name name-style="western"><surname>Cate</surname><given-names>R. L.</given-names></name></person-group> (<year>2004</year>) <article-title>Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model</article-title>. <source>Mol. Endocrinol</source>. <volume>18</volume>, <fpage>708</fpage>â<lpage>721</lpage>
<pub-id pub-id-type="doi">10.1210/me.2003-0358</pub-id>
<?supplied-pmid 14673134?><pub-id pub-id-type="pmid">14673134</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Mi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Walz</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Springer</surname><given-names>T. A.</given-names></name></person-group> (<year>2011</year>) <article-title>Latent TGF-Î² structure and activation</article-title>. <source>Nature</source>
<volume>474</volume>, <fpage>343</fpage>â<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1038/nature10152</pub-id>
<?supplied-pmid 21677751?><pub-id pub-id-type="pmid">21677751</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Annes</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Munger</surname><given-names>J. S.</given-names></name>, and <name name-style="western"><surname>Rifkin</surname><given-names>D. B.</given-names></name></person-group> (<year>2004</year>) <article-title>Integrin Î±VÎ²6-mediated activation of latent TGF-Î² requires the latent TGF-Î² binding protein-1</article-title>. <source>J. Cell Biol</source>. <volume>165</volume>, <fpage>723</fpage>â<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200312172</pub-id>
<?supplied-pmid 15184403?><pub-id pub-id-type="pmid">15184403</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Munger</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Kawakatsu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Griffiths</surname><given-names>M. J. D.</given-names></name>, <name name-style="western"><surname>Dalton</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pittet</surname><given-names>J.-F.</given-names></name>, <name name-style="western"><surname>Kaminski</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Garat</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Matthay</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Rifkin</surname><given-names>D. B.</given-names></name>, and <name name-style="western"><surname>Sheppard</surname><given-names>D.</given-names></name></person-group> (<year>1999</year>) <article-title>The integrin Î±vÎ²6 binds and activates latent TGFÎ²1: a mechanism for regulating pulmonary inflammation and fibrosis</article-title>. <source>Cell</source>
<volume>96</volume>, <fpage>319</fpage>â<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80545-0</pub-id>
<?supplied-pmid 10025398?><pub-id pub-id-type="pmid">10025398</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wipff</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Rifkin</surname><given-names>D. B.</given-names></name>, <name name-style="western"><surname>Meister</surname><given-names>J. J.</given-names></name>, and <name name-style="western"><surname>Hinz</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>) <article-title>Myofibroblast contraction activates latent TGF-Î²1 from the extracellular matrix</article-title>. <source>J. Cell Biol</source>. <volume>179</volume>, <fpage>1311</fpage>â<lpage>1323</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200704042</pub-id>
<?supplied-pmid 18086923?><pub-id pub-id-type="pmid">18086923</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Hudson</surname><given-names>N. E.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Springer</surname><given-names>T. A.</given-names></name></person-group> (<year>2014</year>) <article-title>Structural determinants of integrin Î²-subunit specificity for latent TGF-Î²</article-title>. <source>Nat. Struct. Mol. Biol</source>. <volume>21</volume>, <fpage>1091</fpage>â<lpage>1096</lpage>
<pub-id pub-id-type="doi">10.1038/nsmb.2905</pub-id>
<?supplied-pmid 25383667?><pub-id pub-id-type="pmid">25383667</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Iacob</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Koksal</surname><given-names>A. C.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Engen</surname><given-names>J. R.</given-names></name>, and <name name-style="western"><surname>Springer</surname><given-names>T. A.</given-names></name></person-group> (<year>2017</year>) <article-title>Force interacts with macromolecular structure in activation of TGF-Î²</article-title>. <source>Nature</source>
<volume>542</volume>, <fpage>55</fpage>â<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1038/nature21035</pub-id>
<?supplied-pmid 28117447?><pub-id pub-id-type="pmid">28117447</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Little</surname><given-names>S. C.</given-names></name>, and <name name-style="western"><surname>Mullins</surname><given-names>M. C.</given-names></name></person-group> (<year>2009</year>) <article-title>Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis</article-title>. <source>Nat. Cell Biol</source>. <volume>11</volume>, <fpage>637</fpage>â<lpage>643</lpage>
<pub-id pub-id-type="doi">10.1038/ncb1870</pub-id>
<?supplied-pmid 19377468?><pub-id pub-id-type="pmid">19377468</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sali</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Blundell</surname><given-names>T. L.</given-names></name></person-group> (<year>1993</year>) <article-title>Comparative protein modelling by satisfaction of spatial restraints</article-title>. <source>J. Mol. Biol</source>. <volume>234</volume>, <fpage>779</fpage>â<lpage>815</lpage>
<pub-id pub-id-type="doi">10.1006/jmbi.1993.1626</pub-id>
<?supplied-pmid 8254673?><pub-id pub-id-type="pmid">8254673</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>I. W.</given-names></name>, <name name-style="western"><surname>Leaver-Fay</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>V. B.</given-names></name>, <name name-style="western"><surname>Block</surname><given-names>J. N.</given-names></name>, <name name-style="western"><surname>Kapral</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>L. W.</given-names></name>, <name name-style="western"><surname>Arendall</surname><given-names>W. B.</given-names><suffix>3rd</suffix></name>, <name name-style="western"><surname>Snoeyink</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>J. S.</given-names></name>, and <name name-style="western"><surname>Richardson</surname><given-names>D. C.</given-names></name></person-group> (<year>2007</year>) <article-title>MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</article-title>. <source>Nucleic Acids Res</source>. <volume>35</volume>, <fpage>W375</fpage>â<lpage>W383</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkm216</pub-id>
<?supplied-pmid 17452350?><pub-id pub-id-type="pmid">17452350</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mi</surname><given-names>L.-Z.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>C. T.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>V. Q.</given-names></name>, <name name-style="western"><surname>Walz</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Springer</surname><given-names>T. A.</given-names></name></person-group> (<year>2015</year>) <article-title>Structure of bone morphogenetic protein 9 procomplex</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>112</volume>, <fpage>3710</fpage>â<lpage>3715</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1501303112</pub-id>
<?supplied-pmid 25751889?><pub-id pub-id-type="pmid">25751889</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>HyvÃ¶nen</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>) <article-title>Structure and activation of pro-activin A</article-title>. <source>Nat. Commun</source>. <volume>7</volume>, <fpage>12052</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms12052</pub-id>
<?supplied-pmid 27373274?><pub-id pub-id-type="pmid">27373274</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ying</surname><given-names>S. Y.</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Shimasaki</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Esch</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Hotta</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Guillemin</surname><given-names>R.</given-names></name></person-group> (<year>1986</year>) <article-title>Pituitary FSH is released by a heterodimer of the Î²-subunits from the two forms of inhibin</article-title>. <source>Nature</source>
<volume>321</volume>, <fpage>779</fpage>â<lpage>782</lpage>
<pub-id pub-id-type="doi">10.1038/321779a0</pub-id>
<?supplied-pmid 3086749?><pub-id pub-id-type="pmid">3086749</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hsueh</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Dahl</surname><given-names>K. D.</given-names></name>, <name name-style="western"><surname>Vaughan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tucker</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Rivier</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bardin</surname><given-names>C. W.</given-names></name>, and <name name-style="western"><surname>Vale</surname><given-names>W.</given-names></name></person-group> (<year>1987</year>) <article-title>Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>84</volume>, <fpage>5082</fpage>â<lpage>5086</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.84.14.5082</pub-id>
<?supplied-pmid 3474640?><pub-id pub-id-type="pmid">3474640</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aono</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hazama</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Notoya</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Taketomi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yamasaki</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tsukuda</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Fujisawa</surname><given-names>Y.</given-names></name></person-group> (<year>1995</year>) <article-title>Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer</article-title>. <source>Biochem. Biophys. Res. Commun</source>. <volume>210</volume>, <fpage>670</fpage>â<lpage>677</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.1995.1712</pub-id>
<?supplied-pmid 7763240?><pub-id pub-id-type="pmid">7763240</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kaneko</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Maeda</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Ueno</surname><given-names>N.</given-names></name></person-group> (<year>1997</year>) <article-title>Mesoderm induction by BMP-4 and -7 heterodimers</article-title>. <source>Biochem. Biophys. Res. Commun</source>. <volume>232</volume>, <fpage>153</fpage>â<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.1997.6219</pub-id>
<?supplied-pmid 9125121?><pub-id pub-id-type="pmid">9125121</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nishimatsu</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Thomsen</surname><given-names>G. H.</given-names></name></person-group> (<year>1998</year>) <article-title>Ventral mesoderm induction and patterning by bone morphogenetic protein heterodimers in Xenopus embryos</article-title>. <source>Mech. Dev</source>. <volume>74</volume>, <fpage>75</fpage>â<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/S0925-4773(98)00070-7</pub-id>
<?supplied-pmid 9651485?><pub-id pub-id-type="pmid">9651485</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Buijs</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>van der Horst</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>van den Hoogen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>de Rooij</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kroon</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van Overveld</surname><given-names>P. G.</given-names></name>, <name name-style="western"><surname>Pelger</surname><given-names>R. C.</given-names></name>, and <name name-style="western"><surname>van der Pluijm</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>) <article-title>The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation</article-title>. <source>Oncogene</source>
<volume>31</volume>, <fpage>2164</fpage>â<lpage>2174</lpage>
<pub-id pub-id-type="doi">10.1038/onc.2011.400</pub-id>
<?supplied-pmid 21996751?><pub-id pub-id-type="pmid">21996751</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>Z.</given-names></name>, and <name name-style="western"><surname>Wu</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>) <article-title>BMP2/7 heterodimer can modulate all cellular events of the <italic>in vitro</italic> RANKL-mediated osteoclastogenesis, respectively, in different dose patterns</article-title>. <source>Tissue Eng. Part A</source>
<volume>18</volume>, <fpage>621</fpage>â<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1089/ten.tea.2011.0366</pub-id>
<?supplied-pmid 21981321?><pub-id pub-id-type="pmid">21981321</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Israel</surname><given-names>D. I.</given-names></name>, <name name-style="western"><surname>Nove</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kerns</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Kaufman</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Rosen</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>K. A.</given-names></name>, and <name name-style="western"><surname>Wozney</surname><given-names>J. M.</given-names></name></person-group> (<year>1996</year>) <article-title>Heterodimeric bone morphogenetic proteins show enhanced activity <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>Growth Factors</source>
<volume>13</volume>, <fpage>291</fpage>â<lpage>300</lpage>
<pub-id pub-id-type="doi">10.3109/08977199609003229</pub-id>
<?supplied-pmid 8919035?><pub-id pub-id-type="pmid">8919035</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Kabsch</surname><given-names>W.</given-names></name></person-group> (<year>2001</year>) <article-title>F, Crystallography of biological macromolecules</article-title>. in <source>International Tables for Crystallography</source> (<person-group person-group-type="editor"><name name-style="western"><surname>Rossmann</surname><given-names>M. G.</given-names></name>, and <name name-style="western"><surname>Arnold</surname><given-names>E.</given-names></name></person-group>, eds) pp <fpage>730</fpage>â<lpage>734</lpage>, <publisher-name>Kluwer Academic Publishers</publisher-name>, <publisher-loc>Dordrecht, Netherlands</publisher-loc></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Karplus</surname><given-names>P. A.</given-names></name>, and <name name-style="western"><surname>Diederichs</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>) <article-title>Linking crystallographic model and data quality</article-title>. <source>Science</source>
<volume>336</volume>, <fpage>1030</fpage>â<lpage>1033</lpage>
<pub-id pub-id-type="doi">10.1126/science.1218231</pub-id>
<?supplied-pmid 22628654?><pub-id pub-id-type="pmid">22628654</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>McCoy</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>P. D.</given-names></name>, <name name-style="western"><surname>Winn</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Storoni</surname><given-names>L. C.</given-names></name>, and <name name-style="western"><surname>Read</surname><given-names>R. J.</given-names></name></person-group> (<year>2007</year>) <article-title>Phaser crystallographic software</article-title>. <source>J. Appl. Crystallogr</source>. <volume>40</volume>, <fpage>658</fpage>â<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id>
<?supplied-pmid 19461840?><pub-id pub-id-type="pmid">19461840</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>P. D.</given-names></name>, <name name-style="western"><surname>Afonine</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>BunkÃ³czi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>V. B.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>I. W.</given-names></name>, <name name-style="western"><surname>Echols</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Headd</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Hung</surname><given-names>L. W.</given-names></name>, <name name-style="western"><surname>Kapral</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>, <name name-style="western"><surname>McCoy</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Moriarty</surname><given-names>N. W.</given-names></name>, <name name-style="western"><surname>Oeffner</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Read</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>D. C.</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Terwilliger</surname><given-names>T. C.</given-names></name>, and <name name-style="western"><surname>Zwart</surname><given-names>P. H.</given-names></name></person-group> (<year>2010</year>) <article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr</source>. <volume>66</volume>, <fpage>213</fpage>â<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id>
<?supplied-pmid 20124702?><pub-id pub-id-type="pmid">20124702</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>M. Y.</given-names></name>, and <name name-style="western"><surname>Sali</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>) <article-title>Statistical potential for assessment and prediction of protein structures</article-title>. <source>Protein Sci</source>. <volume>15</volume>, <fpage>2507</fpage>â<lpage>2524</lpage>
<pub-id pub-id-type="doi">10.1110/ps.062416606</pub-id>
<?supplied-pmid 17075131?><pub-id pub-id-type="pmid">17075131</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>